Echocardiographic Findings of Malignant Lymphoma with Cardiac Involvement: A Single-center Retrospective

Toshiaki Ebina1, Yuka Sano1, Michiko Hirabayashi1

  • 1Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Japan.

Insights

Cardiac involvement in malignant lymphoma (ML) is uncommon (1.5%), particularly in diffuse large B-cell lymphoma (DLBCL). Transthoracic echocardiography (TTE) is valuable for detecting cardiac issues and monitoring treatment response in ML patients.

Area of Science:

  • Cardiology
  • Oncology
  • Medical Imaging

Background:

  • Malignant lymphoma (ML) can affect any organ, making cardiac involvement challenging to diagnose without overt symptoms.
  • Early detection of cardiac involvement in ML is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of cardiac involvement in ML patients.
  • To identify transthoracic echocardiography (TTE) findings associated with cardiac involvement in ML.

Main Methods:

  • Retrospective review of 453 ML patients from January 2013 to December 2019.
  • Analysis of TTE data for 394 patients who underwent the procedure at diagnosis or during their clinical course.
  • Evaluation of specific lymphoma subtypes, including diffuse large B-cell lymphoma (DLBCL).

Main Results:

  • Cardiac involvement was detected in 1.5% (6 out of 394) of ML patients who underwent TTE.
  • Diffuse large B-cell lymphoma (DLBCL) was the most frequent type of ML with cardiac involvement.
  • Pericardial effusion was observed in five patients; cardiac lesions varied, and left ventricular ejection fraction was preserved in most.

Conclusions:

  • Cardiac involvement in ML is infrequent but occurs, with B-cell lymphomas, especially DLBCL, being commonly implicated.
  • Transthoracic echocardiography (TTE) is an effective non-invasive tool for assessing cardiac involvement, treatment response, and cardiac function in ML patients.
  • While pericardial effusion is a common finding, the spectrum of cardiac lesions in ML is diverse.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
26
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
388